4.7 Article

The role of daurisoline treatment in hepatocellular carcinoma: Inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Evolution of Systemic Therapy for Hepatocellular Carcinoma

Richard S. Finn et al.

Summary: In recent years, there has been a shift in focus towards novel drug development for hepatocellular carcinoma (HCC) with attention being given to immune-oncology approaches. While there have been significant advancements in phase 3 studies in advanced HCC, there is still a need to optimize patient selection criteria and combination strategies to fully utilize the potential of these approaches in clinical practice. The next generation of studies will aim to translate the enhanced understanding of tumor biology into improved clinical trial designs.

HEPATOLOGY (2021)

Article Peripheral Vascular Disease

RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway

Kailiang Qiao et al.

Summary: This study revealed that m6A methylation plays a key role in vasculogenic mimicry (VM) formation in hepatocellular carcinoma (HCC), and METTL3 and YAP1 could be potential therapeutic targets for anti-metastatic strategies by impairing VM formation.

ANGIOGENESIS (2021)

Article Biochemistry & Molecular Biology

Daurisoline inhibits hepatocellular carcinoma progression by restraining autophagy and promoting cispaltin-induced cell death

Legang Xue et al.

Summary: The study revealed that Daurisoline (DAS) can enhance the sensitivity of HCC cells to cisplatin chemotherapy by inhibiting lysosomal acidification. In vivo experiments also demonstrated significant suppression of tumor progression when DAS was combined with cisplatin.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Article Oncology

Stem-like tumor cells involved in heterogeneous vasculogenesis in breast cancer

Yuling Mao et al.

ENDOCRINE-RELATED CANCER (2020)

Review Cell Biology

Mitochondria as multifaceted regulators of cell death

Florian J. Bock et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

miR-154-3p and miR-487-3p synergistically modulate RHOA signaling in the carcinogenesis of thyroid cancer

Xiang-da Fan et al.

BIOSCIENCE REPORTS (2020)

Review Immunology

Targeting ROCK signaling in health, malignant and non-malignant diseases

Roya Shahbazi et al.

IMMUNOLOGY LETTERS (2020)

Review Gastroenterology & Hepatology

Tumour evolution in hepatocellular carcinoma

Amanda J. Craig et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Oncology

Vasculogenic mimicry in carcinogenesis and clinical applications

Qingxi Luo et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Review Pharmacology & Pharmacy

Druggable targets in the Rho pathway and their promise for therapeutic control of blood pressure

Rachel A. Dee et al.

PHARMACOLOGY & THERAPEUTICS (2019)

Article Biochemistry & Molecular Biology

RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma

Ji-Gang Zhang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)

Review Oncology

Systemic Treatment for Advanced Hepatocellular Carcinoma

Mohamed Bouattour et al.

LIVER CANCER (2019)

Review Immunology

Caspases in Cell Death, Inflammation, and Disease

Nina Van Opdenbosch et al.

IMMUNITY (2019)

Article Biotechnology & Applied Microbiology

ARHGAP10 Inhibits the Proliferation and Metastasis of CRC Cells via Blocking the Activity of RhoA/AKT Signaling Pathway

Lin Liu et al.

ONCOTARGETS AND THERAPY (2019)

Article Biochemistry & Molecular Biology

Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42

Gina L. Razidlo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Review Biochemistry & Molecular Biology

New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies

Leilei Niu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)

Review Pharmacology & Pharmacy

Rho Kinases in Health and Disease: From Basic Science to Translational Research

Gervaise Loirand

PHARMACOLOGICAL REVIEWS (2015)

Article Biochemistry & Molecular Biology

RhoA/Rho kinase up-regulate bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis

Dominic P. Del Re et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)